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Abstract
Objectives. To analyse predictors and outcomes of major orthopaedic surgery in a cohort of RA patients
followed for 20 years.
Methods. Patients were recruited to the Norfolk Arthritis Register from 1990 to 1994. Demographic and
clinical variables (including the HAQ and swollen and tender joint counts) were assessed at baseline; the
2010 ACR/EULAR RA classification criteria were applied. Patients reported incident comorbidities and
major orthopaedic joint surgery (replacement, synovectomy, fusion, excision) when reassessed at years 1,
2, 3, 5, 7, 10, 15 and 20. Baseline and time-varying predictors of orthopaedic surgery were assessed
using a conditional risk set model, a type of multiple-failure survival analysis. Change in disability after
surgery was assessed using weighted mixed-effects linear regression.
Results. Of 589 RA patients [median age 56 years (IQR 4568); 66.7% women] recruited to the Norfolk
Arthritis Register with at least one follow-up, 102 reported a total of 180 major surgeries, with hip re-
placement being the most common (n= 68/180). Patients reporting major surgery had worse functional
disability at all time points, but similar swollen/tender joint counts to those without major surgery. Each
unit increase in HAQ score was associated with a doubling of the patient’s risk of having surgery by the
next assessment [hazard ratio 2.11 per unit increase in HAQ (95% CI 1.64, 2.71)]. Patients had worse HAQ
scores after surgery than patients not undergoing surgery [b= 0.17 (95% CI 0.03, 0.32)].
Conclusion. HAQ was the strongest predictor of future major surgery. This supports the argument that
HAQ should be included in routine clinical assessment.
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Rheumatology key messages
. The Health Assessment Questionnaire was the strongest independent predictor of future orthopaedic joint
surgery.
. Swelling within knee joints strongly predicted knee surgery, suggesting potential benefits of targeted therapy.
. Joint surgery did not improve the overall function of patients; early disease control is essential.
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Introduction
The joint inflammation associated with RA, especially if
persistent, may lead to progressive joint damage [1].
Joint damage and pain are major indications for ortho-
paedic surgery [2, 3]. Over the past two decades the in-
cidence of orthopaedic surgery in patients with RA has
been declining, potentially due to better long-term out-
comes as a consequence of improvements in treatment
[46]. For instance, patients with RA had a 12% lower risk
of undergoing a total knee replacement between 2003 and
2007 compared with 19931997 [7]. However, in a UK
study of RA patients from 1986 to 2011, only hand and
foot orthopaedic surgery rates declined, with large-joint
replacement rates remaining constant over time [8].
Despite this, a significant proportion of RA patients still
require orthopaedic surgery [9], and little research on pre-
dictors of surgery has been conducted. Kapetanovic et al.
[10] followed 183 patients with recent-onset RA in Sweden
for a mean of 16 years and showed that baseline func-
tional disability (HAQ) [hazard ratio (HR) 1.74/1 unit in-
crease in HAQ (95% CI 1.04, 2.93)], baseline CRP [HR
1.39/10 mg/l increase in CRP (95% CI 1.23, 1.46)] and
radiological damage at year 1 [HR 1.47/10 unit increase
in Larsen score (95% CI 1.22, 1.77)] were associated
with an increased risk of first joint replacement surgery.
Moura et al. [11], using Canadian physician billing and
hospitalization databases with a median 4.6 years
follow-up, showed that increased methotrexate exposure
within the first year of RA diagnosis was associated with a
reduced risk of joint replacement compared with no
methotrexate exposure [HR 0.95/month exposure in first
year (95% CI 0.93, 0.97)]. An analysis of patients recruited
from 1986 to 2012 to the Early RA Study/Early RA Network
(ERAS/ERAN) found that high 28-joint DAS (DAS28 >5.1)
between years 1 and 5 was associated with an increased
risk of orthopaedic surgery compared with remission
mean DAS28 (42.6) [HR 2.59 (95% CI 1.49, 4.52)] [12].
These studies give us an insight into the association
between factors early in disease progression and ortho-
paedic surgery, but there is little understanding of the as-
sociation between time-varying factors and surgery. In the
era of stratified medicine, pinpointing patients who are at
high risk for surgery in the next year is perhaps more
useful than identifying patients at moderate risk over the
next 520 years [13]. Furthermore, although it has been
shown that joint erosion is predicted by local inflammation
[14, 15], it is unclear whether swelling, a marker of local
inflammation, and tenderness in a specific joint at the
early stages of the disease process predict later surgery
on that joint. Lastly, observational research on outcomes
after surgery in RA patients often focuses on negative
outcomes and complications [16, 17], and there has
been little research on whether surgery improves patient
outcomes [18].
This study assesses the predictors of and outcomes
following major orthopaedic surgery in an inception
cohort of patients with early RA recruited by the Norfolk
Arthritis Register (NOAR) and followed for 20 years.
The primary objective of this study was to assess the
relationship between baseline and time-varying clinical
and demographic variables and both first and multiple
major joint surgery. Additional objectives were to assess
whether disease activity in a particular joint early after
symptom onset predicts surgery on that joint and to
assess whether functional disability improves following
surgery.
Methods
Patients in this study were recruited to the NOAR between
1990 and 1994. Detailed information on the NOAR can be
found elsewhere [19]. In brief all incident cases of patients
with inflammatory polyarthritis (IP) presenting at primary
care in the former Norwich Health Authority region,
Norfolk UK, were referred to the NOAR by primary care
physicians or their consultant rheumatologists (N= 1098).
The inclusion criteria of the NOAR were age 516 years
and two or more swollen joints lasting for54 weeks. Only
patients recruited within 2 years following symptom onset
were included in this analysis (76 patients were excluded).
The 2010 ACR/EULAR RA criteria were applied retro-
spectively at baseline and only patients classified as RA
according to these criteria were included in the main ana-
lysis (614 patients with RA were included) [20]. Lastly, pa-
tients were required to attend at least one follow-up
assessment to report incident surgery; thus a total of
589 patients were included. Patients gave written in-
formed consent in accordance with the Declaration of
Helsinki and the NOAR was approved by the Norfolk
and Norwich University Hospital Local Research Ethics
Committee. This study, as an analysis of the data from
the NOAR, did not require additional approval.
Assessments
Patients were assessed at baseline and at years 1, 2, 3, 5,
7, 10, 15 and 20. Patients were only assessed beyond
year 5 if they had documented swollen joints on two or
more occasions or had received DMARDs or oral cortico-
steroids by the fifth-year assessment (seven patients were
excluded after follow-up 5). Gender and date of birth were
recorded at baseline. At each assessment patients re-
ported start and stop dates for all prescribed DMARDs
and corticosteroids as well as incident comorbidities,
which were coded based on the International
Classification of Diseases (revisions 9 and 10). A research
nurse performed a 51 joint examination (other than years 5
and 7) and recorded each assessed joint as swollen,
tender or both; swollen (SJC28 and 51) and tender
(TJC28 and 51) joint counts were calculated. The 51
joints included in the assessment were neck, shoulders,
elbows, wrists, MCP joints, PIP joints, DIP joints, hips,
knees, ankles and MTP joints. Patients completed the
British version of the HAQ Disability Index (HAQ-DI) [21].
Blood samples were taken at baseline and every 5 years,
aliquoted and stored in freezers at 80 C. RF (latex test,
positive cut-off 40 units/ml) and anti-CCP antibody (tested
using the Diastat Anti-CCP2 kit, Axis-Shield, Dundee, UK;
cut-off 5 units/ml) positivity were tested from baseline
samples and CRP (mg/l) level at baseline and every
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5 years. The three-component DAS28 (i.e. CRP, SJC28,
TJC28) was calculated [22].
Surgery assessment
Patients reported on four facets of surgery: type, site, lat-
erality and year. Only synovectomy, excision, fusion/arth-
rodesis and replacement surgeries performed on the
shoulder, elbow, wrist, hip, knee or ankle were included
in this analysis. These were grouped as either replace-
ment or non-replacement surgery. Self-reported surgeries
were validated by comparing patient-reported surgical
interventions with those recorded in hospital notes.
Agreement was good (k > 0.90) between whether a sur-
gery took place and the type, site and year of surgery and
therefore self-reported surgeries were used as the out-
come (for details see supplementary data section
Surgery validation procedure and results, available at
Rheumatology Online).
Statistical analysis
Baseline characteristics, stratified by whether or not pa-
tients reported surgery [reported surgery (RS), no reported
surgery (N-RS)], were described using descriptive statis-
tics and compared using either chi-squared or
MannWhitney U tests, depending on the type of data.
A KaplanMeier survival curve was plotted for the time
to the first major surgery. The association between demo-
graphic and clinical variables and risk of first surgery was
analysed using a Cox proportional hazards model; the
proportional hazards assumption was met. Patients were
censored at their last follow-up visit. Initially only baseline
variables were used as predictors in a multivariate model:
age, gender, HAQ score, SJC51, TJC51, anti-CCP2, RF,
CRP and taking DMARDs. In a second model, baseline
age, HAQ score, SJC51, TJC51, CRP and taking
DMARDs were replaced by the equivalent time-varying
variables. If a follow-up assessment did not assess a par-
ticular variable, then the value of that variable at the clo-
sest previous assessment where it was measured was
used. Median age, SJC51, TJC51, HAQ and the number
and proportion of patients taking synthetic DMARDs and
biologic DMARDs at the start of each follow-up window
were reported, stratified by whether a patient had surgery
in the follow-up window. The scores were compared using
chi-squared or MannWhitney U tests, depending on the
type of data. A follow-up window was defined as the time
between two attended follow-ups. Predictors of surgery
(i.e. not just first surgery) were assessed using a condi-
tional risk set model [23]. Each year was considered as a
risk set. Each patient started in risk set 1, indicating no
surgeries and after each surgery patients moved into the
next risk set. Therefore the conditional risk set at a par-
ticular time for the nth surgery is made up of all follow-up
time for patients who had n  1 surgeries [24]. A Cox
proportional hazards model was then used, stratifying by
risk set. The same covariates were used as when analys-
ing the first surgery. The analyses were then limited
to lower limb (hip, knee, ankle) surgery and the HAQ
was substituted with the walking and rising HAQ
subcomponents in two separate models to assess the
association between specific surgery sites and certain
daily activities.
The relationship between early disease activity (swollen
joint at baseline) in a particular joint and subsequent sur-
gery on that joint was assessed using a Cox proportional
hazards model. To assess whether early cumulative dis-
ease activity in a joint was associated with surgery on that
joint, the number of assessments out of the first four at
which the patient was recorded as having swelling in that
joint was used as the independent variable. Follow-up
time for this subanalysis began after the patient’s fourth
assessment, meaning that a number of surgeries were
left-censored (1420%). This subanalysis was limited to
the patients who attended baseline and follow-ups 1, 2
and 3 plus at least one other to report incident surgery.
Due to the low number of surgical interventions for some
joints, the subanalysis was only conducted on the knee
joint and adjusted for age, gender and tenderness. The
analysis was repeated with tender joints at baseline/over
the first four assessments as the independent variable.
To analyse outcome after surgery, the change in HAQ
score over each follow-up window was calculated. Then
the changes in HAQ over follow-up windows where sur-
gery was reported/not reported were compared using a
mixed effects linear regression model, initially only con-
trolling for age and gender. Then a weighted model was
used controlling for gender, baseline RF and anti-CCP2,
time-varying age, SJC51, TJC51, CRP, HAQ and comor-
bidities. As patients who required joint surgery were likely
to have more severe disease and patients who leave the
cohort are likely to be different from those who remain, the
model was weighted using inverse probability of treat-
ment/censoring weights [25, 26]. The analysis was then
limited to lower limb surgeries and the walking and
rising subcomponents of the HAQ to assess whether
lower limb surgery was associated with improvements in
these areas of daily living.
All regression analyses were repeated, confined to the
total the NOAR IP population (n= 964) recruited from 1990
to 1994 and with at least one follow-up (see supplemen-
tary Tables S1S3, available at Rheumatology Online, for
these results). Multiple imputation using chained equa-
tions was performed to account for missing data of pre-
dictors. All analyses were performed using Stata 13.1
(StataCorp, College Station, TX, USA).
Results
A total of 589 patients with RA were included in this ana-
lysis. The analysis included a total of 7185 years of follow-
up (patient-years). All patients contributed at least 1 year
of follow-up, up to a maximum of 20 [mean 12.1 years (S.D.
7.1)]; 260 (44.1%) patients died during follow-up,
116 (19.7%) patients declined further participation in the
project or were lost to follow-up and 213 (36.2%) patients
were assessed at year 20.
Over this time, 206 major surgeries were self-reported
by 102 (17.3%) patients. Of these, 180 were included in
the analysis, as 26 were duplicate reports. The median
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length of time between baseline and the first reported sur-
gery of patients was 8 years [interquartile range (IQR)
412]. These 180 surgeries included 145 (80.5%) replace-
ment surgeries and 35 (19.4%) non-replacement sur-
geries. The most commonly reported surgery was hip
replacement surgery [n= 68 (37.7% of self-reported sur-
geries)] followed by knee replacement surgery [n= 58
(32.2%)] (see supplementary Table S4, available at
Rheumatology Online, for frequencies of all reported sur-
geries). A similar proportion of patients underwent surgery
in the total IP population [n= 151 (15.6%)].
Baseline characteristics
The 589 included patients had a median age at baseline of
56 years (IQR 4568) and 393 (66.7%) were women.
Patients who had surgery and those who did not have
surgery were of similar age at symptom onset [median
age: RS = 57 years (IQR 4766), N-RS = 55 years (IQR
4368)] and included a similar proportion of women (66
vs 71%). The only differences between the groups at
baseline were that patients who subsequently underwent
surgery had lower TJC scores [median TJC28: RS = 7 (IQR
413), N-RS = 10 (IQR 517); median TJC51: RS = 11 (IQR
620), N-RS = 15 (IQR 723)]; higher CRP levels [median
CRP: RS = 9.5 mg/l (IQR 436.3), N-RS = 7 (IQR 118)] and
a higher proportion of anti-CCP2-positive patients
[RS = 55.2% (n= 48), N-RS = 37.8% (n= 148); Table 1].
Predictors of first surgery
Figure 1 shows the KaplanMeier survival curve of time to
first surgery. Age and anti-CCP2 positivity were the only
baseline characteristics independently associated with an
increased risk of first surgery [HR 1.02/year increase in
age (95% CI 1.01, 1.04); HR 1.84 anti-CCP2 positive vs
anti-CCP2 negative (95% CI 1.01, 3.38)]. HAQ scores at
the start of a follow-up window were consistently higher in
the patients who had a surgery within that follow-up
window, whereas there were no differences in the
SJC51, TJC51 and proportion receiving disease-modify-
ing treatment between groups (Table 2). Using time-vary-
ing variables in the Cox regression, the HAQ score at the
beginning of a follow-up window was independently asso-
ciated with the risk of first surgery during that window [HR
2.19/unit increase in HAQ score (95% CI 1.66, 2.88)].
Predictors of multiple surgeries
All 180 surgeries were included in the conditional risk set
analysis. Baseline age [HR 1.01/year (95% CI 1.00, 1.03)]
and anti-CCP2 positivity [HR 1.83 compared with anti-
CCP2 negative (95% CI 1.07, 3.13)] were significantly
TABLE 1 Baseline characteristics of the cohort, stratified by whether they ever reported surgery
Characteristics
Total
cohort
Reported surgery
over follow-up
Did not report surgery
over follow-up
n Median (IQR) n Median (IQR) n Median (IQR) P-value
Age at onset, years 589 56 (4568) 102 57 (4766) 487 55 (4368) 0.814a
Gender, female, n (%) 393 (66.7) 72 (70.6) 321 (65.9) 0.362b
Symptom duration
before baseline
assessment, months
589 5.2 (2.99.7) 102 4.6 (2.99.1) 487 5.4 (2.99.9) 0.461a
Swollen joints
28 589 9 (414) 102 8 (512) 487 9 (415) 0.471a
51 589 11 (618) 102 11 (616) 487 11 (618) 0.834a
Tender joints
28 589 10 (416) 102 7 (413) 487 10 (517) 0.024a
51 589 14 (723) 102 11 (620) 487 15 (723) 0.046a
CRP, mg/l 497 8 (221) 90 9.5 (436.3) 407 7 (118) 0.004a
DAS28 497 4.6 (3.85.6) 90 4.79 (4.015.40) 407 4.59 (3.825.63) 0.664a
HAQ 583 1.13 (0.501.63) 100 1.13 (0.501.75) 483 1.13 (0.501.63) 0.332a
Smoking status, n (%) 589 102 487
Never 176 (29.9) 30 (29.4) 146 (30.0) 0.013b
Ever 252 (42.8) 55 (53.9) 197 (40.5)
Current 161 (27.3) 17 (16.7) 144 (29.6)
RF status, n (%) 536 96 440
Positive 214 (39.9) 42 (43.8) 172 (39.1) 0.398b
Negative 322 (60.1) 54 (56.3) 268 (60.9)
Anti-CCP2 status, n (%) 479 87 392
Positive 196 (40.9) 48 (55.2) 148 (37.8) 0.003b
Negative 283 (59.1) 39 (44.8) 244 (62.2)
Taking sDMARDs, n (%) 120 (20.4) 25 (24.5) 95 (19.5) 0.254b
Follow-up time, person-years 7185 1633 5552
aMann-Whitney U test. bChi-squared test. IQR: interquartile range.
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associated with an increased risk of surgery during follow-
up. The HAQ score at the start of a follow-up window in-
dependently predicted having surgery within that follow-up
window [HR 2.11/unit increase in HAQ (95% CI 1.64, 2.71)].
Walking and rising subcomponents of the HAQ
There was no significant association between the baseline
score for the HAQ walking subcomponent [HR 0.85/unit
increase (95% CI 0.63, 1.13)] or the rising subcomponent
[HR 1.39/unit increase (95% CI 0.95, 2.06)] and the risk of
lower limb surgery. However, there were significant asso-
ciations between these scores at the start of a follow-up
window and lower limb surgery within that window [HR
1.70/unit increase in walking subcomponent (95% CI
1.35, 2.14); HR 1.38/unit increase in rising subcomponent
(95% CI 1.07, 1.78)].
Disease activity in a particular joint and surgery on
that joint
Having a swollen knee at baseline was associated with a
doubling of the risk of requiring surgery on that knee over
the follow-up (Table 3). Furthermore, the risk of knee sur-
gery increased as the number of assessments increased
at which patients were found to have swelling in that knee
(Table 3). There was no association between baseline/cu-
mulative tender knee joint and subsequent knee surgery.
Similar results were seen when the analyses were con-
fined to the whole IP population and to replacement sur-
geries (supplementary Table S5, available at
Rheumatology Online).
Outcome after surgery
Patients who had a surgery in a follow-up window had
greater deterioration in the HAQ score over that follow-up
window than patients who did not have a surgery, in an
age- and gender-adjusted model (Table 4). After weighting
the model to attempt to account for confounding by indi-
cation, patients who required surgery still had a greater
deterioration in HAQ scores over follow-up windows com-
pared with patients who did not have surgery. Similar
FIG. 1 A KaplanMeier graph showing the time to the first
major orthopaedic surgery
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results were seen when limiting the analysis to walking and
rising subscales of the HAQ and lower limb surgery.
Discussion
Within the NOAR cohort, 17.3% of RA patients
required at least one major orthopaedic surgery over
the course of 20 years and therefore it would appear
the need for orthopaedic surgery has fallen in recent
years. A study of 1600 prevalent RA patients recruited
in 1974 in the USA found that 33.8% required any
orthopaedic surgery and 17.8% of patients required
total joint replacement over 23 years [27]. A study fol-
lowing 112 RA patients from 1964 to 1986 in Droitwich,
TABLE 3 Baseline and cumulative knee joint disease activity association with subsequent knee joint surgery
First left knee surgery First right knee surgery
Baseline
Number of surgeries included in the analysis 28 31
Time included in the analysis (years) 6998 6970
Swollen joint (compared with not swollen), HR (95% CI) 1.71 (0.71, 4.07) 2.54 (1.17, 5.50)
Tender joint (compared with not tender), HR (95% CI) 0.90 (0.39, 2.09) 0.91 (0.42, 1.98)
Cumulative
Number of surgeries included in the analysis 24 28
Time included in the analysis (years) 5079 5073
Number of assessments out of first four
where joint was swollen, HR (95% CI)
0, [n] [266] 1 [229] 1
1, [n] [100] 3.04 (0.81, 11.46) [122] 3.06 (0.91, 10.29)
2, [n] [50] 9.65 (2.26, 41.18) [57] 4.72 (1.30, 17.19)
3, [n] [39] 8.87 (1.90, 41.34) [39] 6.82 (1.62, 28.81)
4, [n] [9] 16.29 (2.16, 122.52) [17] 12.14 (2.17, 67.80)
Number of assessments out of first four
where joint was tender, HR (95% CI)
0, [n] [190] 1 [177] 1
1, [n] [120] 0.59 (0.16, 2.24) [124] 5.82 (1.23, 27.56)
2, [n] [73] 0.44 (0.10, 1.90) [82] 2.87 (0.51, 16.32)
3, [n] [47] 0.46 (0.10, 2.15) [45] 3.91 (0.61, 25.02)
4, [n] [34] 0.45 (0.09, 2.26) [36] 2.00 (0.27, 14.92)
Covariates included in baseline models: age at onset, gender and swollen joint count and tender joint count at baseline.
Covariates included in cumulative models: age at onset, gender and number of assessments out of the first four where the
patient had a swollen joint and the number that had tender joints on the outcome joint. HR: hazard ratio.
TABLE 4 Change in HAQ scores over follow-up windows; reported surgery vs no reported surgery
Comparison
RA patients  adjusted
for age, gender and HAQ
at the start of
follow-up window,
b (95% CI)
RA patients 
further adjusted,a
b (95% CI)
Total IP cohort  adjusted
for age, gender and HAQ
at the start of the
follow-up window,
b (95% CI)
Total IP cohort 
further adjusted,a
b (95% CI)
Change in HAQ score over the follow-up window
Did not have surgery 0 0 0 0
Had surgery 0.18 (0.09, 0.27) 0.17 (0.03, 0.32) 0.17 (0.11, 0.24) 0.20 (0.08, 0.33)
Did not have replacement surgery 0 0 0 0
Had replacement surgery 0.16 (0.06, 0.26) 0.14 (0.01, 0.29) 0.16 (0.08, 0.24) 0.20 (0.07, 0.34)
Change in walking subcomponent over the follow-up
Did not have lower limb surgery 0 0 0 0
Had lower limb surgeryb 0.27 (0.13, 0.41) 0.27 (0.06, 0.48) 0.28 (0.17, 0.38) 0.27 (0.07, 0.47)
Did not have lower limb replacement surgery 0 0 0 0
Had lower limb replacement surgeryb 0.23 (0.09, 0.37) 0.21 (0.01, 0.42) 0.18 (0.07, 0.29) 0.19 (0.01, 0.40)
Change in rising subcomponent over the follow-up
Did not have lower limb surgery 0 0 0 0
Had lower limb surgeryb 0.23 (0.10, 0.36) 0.17 (0.07, 0.41) 0.19 (0.09, 0.30) 0.30 (0.10, 0.49)
Did not have lower limb replacement surgery 0 0 0 0
Had lower limb replacement surgeryb 0.16 (0.02, 0.29) 0.13 (0.10, 0.36) 0.19 (0.09, 0.30) 0.30 (0.10, 0.49)
aControlling for baseline anti-CCP2, gender, 2010 RA status and RF; time-varying: age, CRP, SJC51, TJC51, comorbidities
and HAQ score at the start of a follow-up window. bLower limb surgeries included hip, knee or ankle surgery.
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UK reported 26.8% of patients required reconstructive
surgery [28].
Despite the reduction in frequency of orthopaedic sur-
gery in the modern era, time-varying HAQ scores were
strongly associated with an increased risk of surgery in
both the 1974 US study and within this analysis [27].
An association between HAQ score and subsequent
orthopaedic surgery was also reported from the Lund
early RA cohort [10] and the Utrecht Rheumatoid
Arthritis Cohort [29]. HAQ score has also been shown to
predict premature mortality [30] and work disability [31,
32] in patients with IP, emphasizing the value of regular
measurement of the HAQ in routine clinical practice.
Furthermore, this analysis demonstrated a strong asso-
ciation between knee swelling and subsequent surgery of
that knee. Similar results were reported from a Japanese
cohort of 1134 prevalent cases of RA followed for 5 years,
with total knee replacement as the outcome [knee involve-
ment at baseline vs no knee involvement: HR 4.01 (95% CI
2.46, 6.52)] [33]. However, Yasui et al. [33] combined left
and right knee activity and used this to predict later knee
arthroplasty. Our analysis suggests that, to reduce the
need for joint surgery, it may be important to target swel-
ling in individual joints and not to focus solely on lowering
the total SJC.
Lastly, this analysis showed that HAQ scores increased
in patients who had surgery compared with patients who
did not, even after attempting to control for confounding
by indication. This could be because joint surgery is asso-
ciated with reduced function in that joint or it could be that
function improves in the operated joint but continues to
deteriorate in non-operated joints. In other words patients
who require joint surgery may have generally worse dis-
ease and operating on a single joint may have little impact
on function in general.
Furthermore, if all patients who would benefit from sur-
gery undergo surgery, there may be no overlap between
the surgery and the non-surgery groups in terms of their
combination of confounders, meaning that any attempt to
balance the covariates using weighting is likely to be in-
effective [26]. Lastly, the time between having surgery and
the first post-operative HAQ score varied up to 5 years or
more. However, restricting the analysis to only include the
first 10 years of follow-up from baseline, and thus limit the
potential time between surgery and assessment, pro-
duced similar results (results not shown).
This study had a number of strengths. This was a large
inception cohort with little selection bias, including data
on many demographic and clinical variables at baseline
and during follow-up, and up to 20 years of follow-up. A
potential weakness of this study is the reliance on patients
self-reporting surgeries; however, these self-reports were
validated by checking hospital records, with good agree-
ment. Another weakness is that we do not know whether
the joint replacements were carried out for the RA-related
damage or primary/secondary OA. Unfortunately BMI was
not measured at baseline in this group of patients and so
we could not explore whether this would have been an
independent predictor of future joint replacement.
Likewise, DAS28 scores over the first 5 years of follow-
up could not be assessed, as blood samples for CRP
measurement were not taken at these time points [12].
In conclusion, we have shown that 17.3% of RA pa-
tients in 199094 underwent at least one major joint sur-
gery in the 20 years following presentation. Hip
replacement was the most common intervention, followed
by knee replacement. The strongest predictor of joint sur-
gery in both the short and long-term was the HAQ score.
Regular measurement of the HAQ in routine clinical prac-
tice may help identify those who should be considered for
surgery. However, joint surgery was not associated with
an improvement in HAQ score in the medium to long term.
This suggests that focusing on disease control in order to
reduce the progression of joint damage and need for joint
surgery is the best treatment strategy.
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